E. Onorati

ORCID: 0009-0003-3996-0914
Publications
Citations
Views
---
Saved
---
About
Contact & Profiles
Research Areas
  • Cancer Genomics and Diagnostics
  • Advanced Breast Cancer Therapies
  • Lung Cancer Research Studies
  • Cancer Treatment and Pharmacology
  • Glioma Diagnosis and Treatment
  • Pancreatic and Hepatic Oncology Research
  • Advanced Radiotherapy Techniques
  • Neuroendocrine Tumor Research Advances
  • Medical Imaging Techniques and Applications
  • Cancer Research and Treatments
  • Advances in Oncology and Radiotherapy
  • HER2/EGFR in Cancer Research
  • Lung Cancer Treatments and Mutations
  • Lung Cancer Diagnosis and Treatment
  • Radiomics and Machine Learning in Medical Imaging
  • Breast Cancer Treatment Studies
  • Hepatocellular Carcinoma Treatment and Prognosis
  • Mobile Health and mHealth Applications
  • Radiation Dose and Imaging

Università Campus Bio-Medico
2023-2024

Campus Bio Medico University Hospital
2024

There is little evidence regarding the safety and efficacy of combination abemaciclib plus radiotherapy (RT). The majority studies investigated RT with palbociclib or ribociclib reporting that hematological toxicity common. Given unique profile greater gastrointestinal compared to toxicity, we wanted evaluate in metastatic breast cancer (BC) patients.

10.1159/000538847 article EN Chemotherapy 2024-06-13

Background: Pancreatic cancer, with its poor prognosis, is frequently diagnosed in elderly patients who may be ineligible for surgery or chemoradiation due to age comorbidities. Stereotactic body radiotherapy (SBRT) offers a targeted approach by delivering precise, high-dose radiation limited volume few fractions. This study aims evaluate the efficacy and safety of SBRT pancreatic cancer patients. Methods: Patients received using Volumetric Modulated Arc Therapy schedules five dose fractions...

10.3390/jcm13247739 article EN Journal of Clinical Medicine 2024-12-18
Coming Soon ...